Net Cash Provided by (Used in) Operating Activities |
4.3B |
USD |
-12.3% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-634M |
USD |
+68.9% |
Q3 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-1.11B |
USD |
+9.33% |
Q3 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
10B |
shares |
0% |
Q2 2025 |
FY 2025 |
Common Stock, Shares, Issued |
4.01B |
shares |
0% |
Q2 2025 |
FY 2025 |
Common Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q2 2025 |
FY 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
2.68B |
USD |
+79.9% |
Q3 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
9.56B |
USD |
+0.78% |
Q2 2025 |
FY 2025 |
Deferred Tax Assets, Valuation Allowance |
293M |
USD |
+1.03% |
Q2 2025 |
FY 2025 |
Operating Lease, Liability |
956M |
USD |
+5.17% |
Q2 2025 |
FY 2025 |
Payments to Acquire Property, Plant, and Equipment |
993M |
USD |
+7.35% |
Q3 2024 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
15.7B |
USD |
+3.49% |
Q2 2025 |
FY 2025 |
Lessee, Operating Lease, Liability, to be Paid |
1.08B |
USD |
+4.66% |
Q2 2025 |
FY 2025 |
Property, Plant and Equipment, Gross |
54.2B |
USD |
+8.23% |
Q2 2025 |
FY 2025 |
Operating Lease, Liability, Current |
255M |
USD |
+4.94% |
Q2 2025 |
FY 2025 |
Operating Lease, Weighted Average Discount Rate, Percent |
0.05 |
pure |
0% |
Q2 2025 |
FY 2025 |
Deferred Income Tax Expense (Benefit) |
184M |
USD |
+80.4% |
Q3 2024 |
Q1 2025 |
Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
123M |
USD |
+0.82% |
Q2 2025 |
FY 2025 |
Unrecognized Tax Benefits |
634M |
USD |
+8.94% |
Q2 2025 |
FY 2025 |
Additional Paid in Capital |
68.8B |
USD |
+1.61% |
Q2 2025 |
FY 2025 |
Amortization of Intangible Assets |
320M |
USD |
-5.33% |
Q2 2025 |
FY 2025 |
Depreciation, Depletion and Amortization |
728M |
USD |
+3.7% |
Q3 2024 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
4.92B |
USD |
+7.27% |
Q2 2025 |
FY 2025 |
Share-based Payment Arrangement, Expense |
476M |
USD |
-15.3% |
Q2 2025 |
FY 2025 |
Interest Expense |
946M |
USD |
+49.9% |
Q1 2024 |
Q3 2024 |